dc.creatorSpinedi, Eduardo Julio
dc.creatorCardinali, Daniel Pedro
dc.creatorGagliardino, Juan Jose
dc.date.accessioned2018-11-06T00:17:31Z
dc.date.available2018-11-06T00:17:31Z
dc.date.created2018-11-06T00:17:31Z
dc.date.issued2017-04
dc.identifierSpinedi, Eduardo Julio; Cardinali, Daniel Pedro; Gagliardino, Juan Jose; Preface; Karger; Neuroendocrinology; 104; 4; 4-2017; 317-318
dc.identifier0028-3835
dc.identifierhttp://hdl.handle.net/11336/63730
dc.identifierCONICET Digital
dc.identifierCONICET
dc.description.abstractIn spite of the increased attention devoted to the literature and by health ministries, overweight and obesity prevalence continues to increase worldwide [1] . A systematic analysis performed in 2013 referred to the global burden of these conditions, and showed that more than 50% of the world’s 671 million obese people live in 10 countries: the United States, China, India, Russia, Brazil, Mexico, Egypt, Germany, Pakistan, and Indonesia [2] . Additionally, overweight/obesity has unhealthy outcomes such as diabetes, hypertension, and cancer [3] .
dc.languageeng
dc.publisherKarger
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.karger.com/Article/Abstract/455076
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1159/000455076
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAdipose Tissue
dc.subjectWhite Physiopathology
dc.subjectCircadian Rhytm Dysfunctions
dc.subjectObesity
dc.titlePreface
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución